안티센스 및 RNAI 치료제 시장 : 기술별, 용도별, 투여 경로별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 및 전망(2023-2030년)

REPORT HIGHLIGHT

Antisense & RNAI Therapeutics Market size was valued at USD 3,800 Million in 2022, expanding at a CAGR of 19.1% from 2023 to 2030.

Antisense technology, acknowledged for gene expression manipulation, stands as a successful treatment avenue for numerous medical conditions. The use of Antisense and RNAi therapies for rare diseases has notably improved therapeutic outcomes. For example, Antisense Oligonucleotides (ASOs) have gained approval for treating rare neurological conditions such as Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA), signaling anticipated growth in the upcoming years. Additionally, augmented R&D funding and a robust product pipeline are expected to drive market expansion. For instance, in January 2023, Agilent invested USD 725 million in expanding manufacturing capabilities for nucleic acid-based therapeutics, including antisense therapies. The scarcity of global treatment options for rare diseases has spurred increased funding and research endeavors focused on developing novel treatments for these conditions.

Antisense & RNAI Therapeutics Market- Market Dynamics

Transformative impact of antisense and RNAi therapeutics in treating rare diseases to propel market demand

The primary factors driving the market are the transformative impact of antisense and RNAi therapeutics in treating rare diseases. By employing gene silencing, these therapies prevent the production of disease-related proteins, notably benefiting conditions like spinal muscular atrophy and heterozygous familial hypercholesterolemia. The precision and selectivity of RNAi treatments, which target disease-causing mRNA, position them as advanced and favored treatments for rare ailments. This surge in demand for RNAi therapeutics acts as a key driver, complemented by increased R&D investment and promising pipeline products, collectively propelling market expansion.

Antisense & RNAI Therapeutics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 19.1% over the forecast period (2023-2030)

Based on Technology segmentation, antisense RNA was predicted to show maximum market share in the year 2022

Based on Route of Administration segmentation, genetic disease was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Antisense & RNAI Therapeutics Market- Segmentation Analysis:

The Global Antisense & RNAI Therapeutics Market is segmented on the basis of Technology, Application, Route of Administration, and Region.

The market is divided into two categories based on Technology: RNA Interference and Antisense RNA. In 2022, the antisense RNA division represented the largest share of revenue. This segment has predominantly led in revenue generation and is actively undergoing trials for managing various conditions. Utilized for regulating both protein and gene expression, this technology exhibits broad applications across cardiovascular, respiratory, neurodegenerative, and genetic disorders, foreseeing significant segmental growth. For instance, a clinical trial at UMass Chan Medical School in December 2021 demonstrated the safe suppression of the mutant amyotrophic lateral sclerosis (ALS) gene using antisense oligonucleotides.

The market is divided into nine categories based on Route of Administration: Genetic Disease, Cancer, Infectious Disease, Neurodegenerative Disorders, Cardio Metabolic & Renal Disorders, Ocular Disorders, Respiratory Disorders, Skin Disorders and Others. The genetic disorder sector commanded the highest revenue share in 2022. The growing necessity to manage diseases like Duchenne muscular dystrophy (DMD) and spinal muscular atrophy is expected to drive the usage of oligonucleotide products. Research endeavors in the realm of oligonucleotide medications are rapidly expanding, evident from the increasing number of research studies. Companies are pursuing regulatory approvals for products designed to treat genetic diseases. For instance, in December 2019, golodirsen, an antisense oligonucleotide therapy for individuals afflicted with DMD, received approval from the Food and Drug Administration (FDA).

Antisense & RNAI Therapeutics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Antisense & RNAI Therapeutics Market- Competitive Landscape:

In the Antisense & RNAi Therapeutics Market, companies deploy various key strategies to bolster their position. They prioritize extensive research and development, investing in cutting-edge technologies to pinpoint precise gene targets and create effective therapeutic molecules. Diversifying pipelines remains a top priority, aiming to encompass a wide array of diseases and broaden market reach. Collaborative partnerships with research institutions and industry counterparts expedite progress and facilitate resource sharing. Concurrently, companies ensure rigorous compliance with regulatory standards, efficiently navigating approval processes. Post-approval, strategic commercialization plans, inclusive of targeted marketing and accessibility initiatives, are vital for successful adoption. Furthermore, continuous advancements in delivery systems are a pivotal focus to optimize therapeutic efficacy. These comprehensive strategies collectively drive the progression and acceptance of antisense and RNAi therapies within the healthcare landscape. Companies capitalize on antisense & RNAi technologies through dedicated advancements.

Recent Developments:

In April 2020, Alnylam Pharmaceuticals, Inc. partnered with Blackstone, with Blackstone investing USD 2 billion to accelerate RNAi therapeutics advancement.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTISENSE & RNAI THERAPEUTICS MARKET KEY PLAYERS

• GSK plc
• Olix Pharmaceuticals, Inc.
• Sanofi
• Alnylam Pharmaceuticals, Inc.
• Arbutus Biopharma
• Benitec Biopharma Inc.
• Silence Therapeutics
• Ionis Pharmaceuticals, Inc
• Bio-Path Holdings Inc.
• Antisense Therapeutics Limited.
• Others

GLOBAL ANTISENSE & RNAI THERAPEUTICS MARKET, BY TECHNOLOGY

• RNA Interference
• Antisense RNA

GLOBAL ANTISENSE & RNAI THERAPEUTICS MARKET, BY APPLICATION

• Neurodegenerative Disorders
• Cardio Metabolic & Renal Disorders
• Genetic Disease
• Cancer
• Infectious Disease
• Ocular Disorders
• Respiratory Disorders
• Skin Disorders
• Others

GLOBAL ANTISENSE & RNAI THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION

• Intravenous Injections
• Intrathecal Injections
• Subcutaneous Injections
• Other Delivery Methods

GLOBAL ANTISENSE & RNAI THERAPEUTICS MARKET, BY REGION

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Antisense & RNAI Therapeutics Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Antisense & RNAI Therapeutics Market Snippet by Technology
  • 2.1.2. Antisense & RNAI Therapeutics Market Snippet by Application
  • 2.1.3. Antisense & RNAI Therapeutics Market Snippet by Route of Administration
  • 2.1.4. Antisense & RNAI Therapeutics Market Snippet by Country
  • 2.1.5. Antisense & RNAI Therapeutics Market Snippet by Region
• 2.2. Competitive Insights

3. Antisense & RNAI Therapeutics Key Market Trends

• 3.1. Antisense & RNAI Therapeutics Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Antisense & RNAI Therapeutics Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Antisense & RNAI Therapeutics Market Opportunities
• 3.4. Antisense & RNAI Therapeutics Market Future Trends

4. Antisense & RNAI Therapeutics Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Antisense & RNAI Therapeutics Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Antisense & RNAI Therapeutics Market Landscape

• 6.1. Antisense & RNAI Therapeutics Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Antisense & RNAI Therapeutics Market - By Technology

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
  • 7.1.2. RNA Interference
  • 7.1.3. Antisense RNA

8. Antisense & RNAI Therapeutics Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
  • 8.1.2. Genetic Disease
  • 8.1.3. Cancer
  • 8.1.4. Infectious Disease
  • 8.1.5. Neurodegenerative Disorders
  • 8.1.6. Cardio Metabolic & Renal Disorders
  • 8.1.7. Ocular Disorders
  • 8.1.8. Respiratory Disorders
  • 8.1.9. Skin Disorders
  • 8.1.10. Others

9. Antisense & RNAI Therapeutics Market - By Route of Administration

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
  • 9.1.2. Intravenous Injections
  • 9.1.3. Intrathecal Injections
  • 9.1.4. Subcutaneous Injections
  • 9.1.5. Other Delivery Methods

10. Antisense & RNAI Therapeutics Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Antisense & RNAI Therapeutics Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Antisense & RNAI Therapeutics Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Antisense & RNAI Therapeutics Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Antisense & RNAI Therapeutics Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Antisense & RNAI Therapeutics Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Antisense & RNAI Therapeutics Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. GSK plc
  • 11.2.2. Olix Pharmaceuticals, Inc.
  • 11.2.3. Sanofi
  • 11.2.4. Alnylam Pharmaceuticals, Inc.
  • 11.2.5. Arbutus Biopharma
  • 11.2.6. Benitec Biopharma Inc.
  • 11.2.7. Silence Therapeutics
  • 11.2.8. Ionis Pharmaceuticals, Inc
  • 11.2.9. Bio-Path Holdings Inc.
  • 11.2.10. Antisense Therapeutics Limited.
  • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us